SFX by Ex Libris Inc.

Title:	Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptidesin vivo: Implications for tumor vaccines with melanoma-associated antigens
Source:	International Journal of Cancer [0020-7136] Jäeger, Elke yr:1996

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Mayordomo, J I I. "Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity." Nature medicine 1.12 (1996): 1297-302.
description	2.	Schulz, M. "Peptide-Induced Antiviral Protection by Cytotoxic T Cells." Proceedings of the National Academy of Sciences of the United States of America 88.3 (1991): 991-993.
description	3.	Weide, B. "Plasmid DNA- and messenger RNA-based anti-cancer vaccination." Immunology letters 115.1 (2007): 33-42.
description	4.	Klinman, D M M. "CpG motifs in bacterial DNA trigger direct B-cell activation." Nature 374.6522 (1995): 546-9.
description	5.	Egen, Jackson G G. "CTLA-4: new insights into its biological function and use in tumor immunotherapy." Nature immunology 3.7 (2002): 611-618.
description	6.	Nestle, F O O. "Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells." Nature medicine 4.3 (1998): 328-32.
description	7.	Mittendorf, Elizabeth A. "The E75 HER2/neu peptide vaccine." Cancer immunology, immunotherapy 57.10 (2008): 1511-1521.
description	8.	Zou, W. "Inhibitory B7-family molecules in the tumour microenvironment." Nature reviews. Immunology 8.6 (2008): 467-77.
description	9.	Lohr, J. "T-cell tolerance and autoimmunity to systemic and tissue-restricted self-antigens." Immunological reviews 204.1 (2005): 116-27.
description	10.	Rosenberg, S A A. "Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma." Nature medicine 4.3 (1998): 321-327.
description	11.	Ashman, R F. "CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry." The journal of immunology (1998): 5898-5906.
description	12.	Krieg, Arthur M. "CpG still rocks! Update on an accidental drug." Nucleic Acid Therapeutics 22.2 (2012): 77-89.
description	13.	Thurner, B. "Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma." The Journal of experimental medicine 190.11 (1999): 1669-1678.
description	14.	Fontenot, Jason D D. "Regulatory T cell lineage specification by the forkhead transcription factor foxp3." Immunity 22.3 (2005): 329-41.
description	15.	Chen, X. "Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells." The journal of immunology 179.4 (2007): 2046-50.
description	16.	Krieg, Arthur M M. "CpG motifs in bacterial DNA and their immune effects." Annual review of immunology 20.1 (2002): 709-60.
description	17.	Wherry, E John J. "Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection." Immunity 27.3 (2007): 393-405.
description	18.	Mockey, M. "mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes." Cancer gene therapy 14.9 (2007): 802-814.
description	19.	Kearney, J. "Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses." Immunity 17.3 (2002): 341-52.
description	20.	Trent, M. "Use of a cDNA microarray to analyse gene expression patterns in human cancer." Nature genetics 14.4 (1997): 457-60.